Accessibility Menu
Aurora Spine logo

Aurora Spine(OTC) ASAPF

Current Price$0.16
Market Cap$12.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-88%
5 Year-70%
1 Year-36%
1 Month+1%
Aurora Spine last closing stock price
MetricPriceDate
Last closeUSD 0.162026-07-22
Aurora Spine stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-11.06%USD 0.182026-07-15
1 month+1.27%USD 0.162026-06-22
3 month-21.37%USD 0.202026-04-23
Year to date-20%USD 0.202025-12-31
1 year-36%USD 0.252025-07-22
3 year-15.79%USD 0.192023-07-21
5 year-70.22%USD 0.542021-07-23
Since inception-88.05%USD 1.342013-09-26

Aurora Spine Financials at a Glance

Market Cap

$12.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$18.35M

Net Income (TTM)

-$580.54K

EPS (TTM)

-$0.01

P/E Ratio

-21.33

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Price

$0.16

Volume

5,000

Open

$0.16

Previous Close

$0.16

Daily Range

$0.16 - $0.16

52-Week Range

$0.15 - $0.25

Estimated Earnings Date

May 27, 2026

ASAPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aurora Spine

Aurora Spine Corporation specializes in the development and distribution of advanced, minimally invasive spine fusion systems and related medical devices. Established in 2013, the company is headquartered in Toronto, Canada, and focuses on innovative solutions for patients suffering from degenerative disc diseases.

Products and Services
  • Interspinous process lumbar fusion devices, including the ZIP and ZIP ULTRA lines
  • Titanium-coated PEEK interbody cages for spinal stability and bone growth
  • 3D-printed spinal implants like the SOLO and DEXA-C systems
Growth Outlook
  • Increasing demand for minimally invasive spine surgeries supports product expansion
  • Innovative product lines position the company for competitive advantage
  • Strategic partnerships may enhance market reach and operational efficiency
Financial Highlights
  • Recent quarterly revenue of $4.37 million, showing resilience in a challenging market
  • Trailing twelve-month gross profit margin of 52.44%, indicating strong product demand
  • Current ratio of 2.53, reflecting solid liquidity and financial health
Aurora Spine Corporation is well-positioned in the medical devices industry, particularly in the spine surgery segment. The company's diverse product offerings cater to a growing market, driven by the increasing prevalence of spinal disorders. Recent financial performance indicates a commitment to innovation and operational efficiency, with a focus on enhancing product lines and expanding market presence. The strong gross profit margin suggests effective cost management and a solid demand for its products. Overall, Aurora Spine presents an intriguing opportunity for investors interested in the healthcare sector, particularly in the evolving landscape of spinal surgery solutions.
AI Generated • Jul 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Trent J. Northcutt

Website

www.aurora-spine.com

Headquarters

Toronto, ON M4S 3B1, CA

ASAPF Financials

Key Financial Metrics (TTM)

Gross Margin

52.44%

Operating Margin

-1.19%

Net Income Margin

-3.24%

Return on Equity

-15.61%

Return on Capital

-5.51%

Return on Assets

-6.11%

Earnings Yield

-4.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

78.09M

Volume

5.00K

Avg. Volume

32.25K

Financials (TTM)

Gross Profit

$6.27M

Operating Income

-$217.74K

EBITDA

$885.11K

Operating Cash Flow

$1.08M

Capital Expenditure

-$373.82K

Free Cash Flow

$706.25K

Cash & ST Invst.

$780.56K

Total Debt

$2.26M

Aurora Spine Performance Analysis

Aurora Spine annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 14,877,32441.1%
20232023-12-31USD 14,520,436-2.4%
20242024-12-31USD 17,562,78221.0%
20252025-12-31USD 18,368,0284.6%
Aurora Spine sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-301.8%
Q32025-09-30-2.6%
Q42025-12-3116.4%
Q12026-03-31-14.2%
Aurora Spine annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.02-44.0%
20232023-12-31USD -0.025.8%
20242024-12-31USD -0.01-45.8%
20252025-12-31USD -0.01-27.1%
Aurora Spine sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3042.2%
Q32025-09-3030.8%
Q42025-12-3166.7%
Q12026-03-31-333.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$4.37M

-1.0%

Gross Profit

$970.07K

-62.1%

Gross Margin

22.18%

N/A

Market Cap

$12.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$694.16K

N/A

Employees

18

N/A

Net Income

-$200.04K

+42.8%

EBITDA

$92.55K

+338.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$780.56K

+59.7%

Total Debt

$2.26M

-38.5%

Accounts Receivable

$3.01M

-26.6%

Inventory

$3.27M

-14.4%

Long Term Debt

$1.93M

-42.5%

Short Term Debt

$332.04K

-47.5%

Return on Assets

-6.11%

N/A

Return on Invested Capital

-3.19%

N/A

Free Cash Flow

-$28.20K

+92.0%

Operating Cash Flow

-$12.67K

+92.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UEECUnited Health Products, Inc.
$0.05-2.00%
VPTDFVentriPoint Diagnostics Ltd.
$0.08+2.50%
ZHCLFZenith Capital Corp.
$0.05+0.00%
IMMVFImmunovia AB
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.28-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.96-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.94+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.28-0.02%

Questions About ASAPF

What is the current price of Aurora Spine?

Aurora Spine is trading at $0.16 per share.

What is the 52-week range for Aurora Spine?

Over the past 52 weeks, Aurora Spine has traded between $0.15 and $0.25.

How much debt does Aurora Spine have?

As of the most recent reporting period, Aurora Spine reported total debt of $2.26M.

How much cash does Aurora Spine have on hand?

Aurora Spine reported $778.01K in cash and cash equivalents in its most recent financial results.

What is Aurora Spine’s dividend yield?

Aurora Spine does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services